This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

Neurologists and endovascular interventionalists may be edging closer to agreement on how to evaluate the controversial vascular theory of multiple sclerosis, but important gaps still appear to divide the two groups.

That was the upshot of a panel discussion held here Monday at the International Symposium on Endovascular Therapy (ISET), featuring the National Multiple Sclerosis Society's (NMSS) chief medical officer -- a neurologist -- along with several representatives of the interventional community and a patient advocate for more aggressive study of the theory.

Like North and South Korea glaring at each other across the demilitarized zone, relations between neurologists and endovascular interventionalists have become tense over the theory that obstructions in the jugular vein disrupt blood outflow in the brain, leading to the nervous-system inflammation characteristic of MS. ... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/2954

Advertisement

They won't get the puzzle together because they still miss one essential piece. Besides the neurological and the vascular dimension, the nutritional/glucose part is important. Therefore, they need to take account of yet another discipline, that of endrocrinologists/diabetes specialists. Further details on: http://www.thisisms.com/ftopict-15188.html

Who is online

This site does not offer, or claim to offer, medical, legal, or professional advice.
All treatment decisions should always be made with the full knowledge of your physicians.
This is MS does not create, endorse, or republish any content.
All postings are the responsibility of the poster. All logos and trademarks in this site are property of their respective owners. All users must respect our rules for intellectual property rights.